ANCA-Associated Vasculitis, Anti-GBM Disease, Lupus Nephritis
By:
Stephen P. McAdooCentre for Inflammatory Disease, Imperial College London, London, United Kingdom
Imperial College Healthcare NHS Trust, London, United Kingdom

Search for other papers by Stephen P. McAdoo in
Current site
Google Scholar
PubMed
Close
and
Charles D. PuseyCentre for Inflammatory Disease, Imperial College London, London, United Kingdom
Imperial College Healthcare NHS Trust, London, United Kingdom

Search for other papers by Charles D. Pusey in
Current site
Google Scholar
PubMed
Close
  • Collapse
  • Expand
  • 1.

    Jennette JC , Falk RJ : Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10: 463473, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Jennette JC : Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol 17: 603606, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Available at: https://kdigo.org/guidelines/gn/. Accessed October 6, 2020

    • Search Google Scholar
    • Export Citation
  • 4.

    Ntatsaki E , Carruthers D , Chakravarty K , D’Cruz D,L , Jayne D , et al.; BSR and BHPR Standards, Guidelines and Audit Working Group: BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford) 53: 23062309, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Yates M , Watts RA , Bajema IM , Cid MC , Crestani B , Hauser T , et al.: EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75: 15831594, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Bossuyt X , Cohen Tervaert JW , Arimura Y , Blockmans D , Flores-Suárez LF , Guillevin L , et al.: Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 13: 683692, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Moiseev S , Cohen Tervaert JW , Arimura Y , Bogdanos DP , Csernok E , Damoiseaux J , et al.: 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmun Rev 19: 102618, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    O’Reilly VP , Wong L , Kennedy C , Elliot LA , O’Meachair S , Coughlan AM , et al.: Urinary soluble CD163 in active renal vasculitis. J Am Soc Nephrol 27: 29062916, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Moran SM , Monach PA , Zgaga L , Cuthbertson D , Carette S , Khalidi NA , et al.: Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant 35: 283291, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Berden AE , Ferrario F , Hagen EC , Jayne DR , Jennette JC , Joh K , et al.: Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21: 16281636, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    van Daalen EE , Wester Trejo MAC , Göçeroğlu A , Ferrario F , Joh K , Noël LH , et al.: Developments in the histopathological classification of ANCA-associated glomerulonephritis. Clin J Am Soc Nephrol 15: 11031111, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Brix SR , Noriega M , Tennstedt P , Vettorazzi E , Busch M , Nitschke M , et al.: Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int 94: 11771188, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    De Groot K , Rasmussen N , Bacon PA , Tervaert JW , Feighery C , Gregorini G , et al.: Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52: 24612469, 2005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Harper L , Morgan MD , Walsh M , Hoglund P , Westman K , Flossmann O , et al.; EUVAS investigators: Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: Long-term follow-up. Ann Rheum Dis 71: 955960, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Stone JH , Merkel PA , Spiera R , Seo P , Langford CA , Hoffman GS , et al.; RAVE-ITN Research Group: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363: 221232, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Jones RB , Tervaert JW , Hauser T , Luqmani R , Morgan MD , Peh CA , et al.; European Vasculitis Study Group: Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363: 211220, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Jones RB , Hiemstra TF , Ballarin J , Blockmans DE , Brogan P , Bruchfeld A , et al.; European Vasculitis Study Group (EUVAS): Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: A randomised, non-inferiority trial. Ann Rheum Dis 78: 399405, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Tuin J , Stassen PM , Bogdan DI , Broekroelofs J , van Paassen P , Cohen Tervaert JW , et al.: Mycophenolate mofetil versus cyclophosphamide for the induction of remission in nonlife-threatening relapses of antineutrophil cytoplasmic antibody-associated vasculitis: Randomized, controlled trial. Clin J Am Soc Nephrol 14: 10211028, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Walsh M , Catapano F , Szpirt W , Thorlund K , Bruchfeld A , Guillevin L , et al.: Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: A meta-analysis. Am J Kidney Dis 57: 566574, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Walters GD , Willis NS , Cooper TE , Craig JC : Interventions for renal vasculitis in adults. Cochrane Database Syst Rev 1: CD003232, 2020 PubMed

    • Search Google Scholar
    • Export Citation
  • 21.

    Walsh M , Merkel PA , Peh CA , Szpirt WM , Puéchal X , Fujimoto S , et al.; PEXIVAS Investigators: Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med 382: 622631, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Cortazar FB , Muhsin SA , Pendergraft WF 3rd , Wallace ZS , Dunbar C , Laliberte K , et al.: Combination therapy with rituximab and cyclophosphamide for remission induction in ANCA vasculitis. Kidney Int Rep 3: 394402, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    McAdoo SP , Medjeral-Thomas N , Gopaluni S , Tanna A , Mansfield N , Galliford J , et al.: Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis. Nephrol Dial Transplant 34: 6373, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Pepper RJ , McAdoo SP , Moran SM , Kelly D , Scott J , Hamour S , et al.: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 58: 260268, 2019 PubMed

    • Search Google Scholar
    • Export Citation
  • 25.

    Walsh M , Merkel PA , Mahr A , Jayne D : Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysis. Arthritis Care Res (Hoboken) 62: 11661173, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26.

    Chen M , Jayne DRW , Zhao MH : Complement in ANCA-associated vasculitis: mechanisms and implications for management. Nat Rev Nephrol 13: 359367, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27.

    Jayne DRW , Bruchfeld AN , Harper L , Schaier M , Venning MC , Hamilton P , et al.; CLEAR Study Group: Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol 28: 27562767, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28.

    Jayne D , Rasmussen N , Andrassy K , Bacon P , Tervaert JW , Dadoniené J , et al.; European Vasculitis Study Group: A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349: 3644, 2003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29.

    Hiemstra TF , Walsh M , Mahr A , Savage CO , de Groot K , Harper L , et al.; European Vasculitis Study Group (EUVAS): Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: A randomized controlled trial. JAMA 304: 23812388, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Karras A , Pagnoux C , Haubitz M , Groot K , Puechal X , Tervaert JWC , et al.; European Vasculitis Society: Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis. Ann Rheum Dis 76: 16621668, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31.

    Guillevin L , Pagnoux C , Karras A , Khouatra C , Aumaître O , Cohen P , et al.; French Vasculitis Study Group: Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 371: 17711780, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Terrier B , Pagnoux C , Perrodeau É , Karras A , Khouatra C , Aumaître O , et al.; French Vasculitis Study Group: Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides. Ann Rheum Dis 77: 11501156, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33.

    Charles P , Terrier B , Perrodeau É , Cohen P , Faguer S , Huart A , et al.; French Vasculitis Study Group: Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: Results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2). Ann Rheum Dis 77: 11431149, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    van Dam LS , Dirikgil E , Bredewold EW , Ray A , Bakker JA , van Kooten C , et al.: Proteinase-3-anti-neutrophil cytoplasmic antibodies (PR3-ANCAs) predict relapses in ANCA-associated vasculitis patients after rituximab [published online ahead of print June 30, 2020]. Nephrol Dial Transplant doi: 10.1093/ndt/gfaa066.2020 PubMed

    • Search Google Scholar
    • Export Citation
  • 35.

    Tieu J , Smith R , Basu N , Brogan P , D’Cruz D , Dhaun N , et al.: Rituximab for maintenance of remission in ANCA-associated vasculitis: Expert consensus guidelines. Rheumatology (Oxford) 59: e24e32, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36.

    Wallace ZS , Fu X , Harkness T , Stone JH , Zhang Y , Choi H : All-cause and cause-specific mortality in ANCA-associated vasculitis: Overall and according to ANCA type. Rheumatology (Oxford) 59: 23082315, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37.

    Tan JA , Dehghan N , Chen W , Xie H , Esdaile JM , Avina-Zubieta JA : Mortality in ANCA-associated vasculitis: A meta-analysis of observational studies. Ann Rheum Dis 76: 15661574, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38.

    Flossmann O , Berden A , de Groot K , Hagen C , Harper L , Heijl C , et al.; European Vasculitis Study Group: Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70: 488494, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39.

    McGovern D , Williams SP , Parsons K , Farrah TE , Gallacher PJ , Miller-Hodges E , et al.: Long-term outcomes in elderly patients with ANCA-associated vasculitis. Rheumatology (Oxford) 59: 10761083, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40.

    Waki D , Nishimura K , Tokumasu H , Kadoba K , Mukoyama H , Saito R , et al.: Initial high-dose corticosteroids and renal impairment are risk factors for early severe infections in elderly patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: A retrospective observational study. Medicine (Baltimore) 99: e19173, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41.

    Weiner M , Goh SM , Mohammad AJ , Hruskova Z , Tanna A , Bruchfeld A , et al.: Outcome and treatment of elderly patients with ANCA-associated vasculitis. Clin J Am Soc Nephrol 10: 11281135, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42.

    McAdoo SP , Pusey CD : Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol 12: 11621172, 2017 PubMed

  • 43.

    Canney M , O’Hara PV , McEvoy CM , Medani S , Connaught DM , Abdalla AA , et al.: Spatial and temporal clustering of anti-glomerular basement membrane disease. Clin J Am Soc Nephrol 11: 13921399, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44.

    Gu QH , Xie LJ , Jia XY , Ma R , Liao YH , Cue Z , et al.: Fever and prodromal infections in anti-glomerular basement membrane disease. Nephrology (Carlton) 23: 476482, 018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45.

    Prendecki M , Clarke C , Cairns T , Cook T , Roufosse C , Thomas D , et al.: Anti-glomerular basement membrane disease during the COVID-19 pandemic. Kidney Int 98: 780781, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 46.

    Ooi JD , Chang J , O’Sullivan KM , Pedchenko V , Hudson BG , Vandenbark AA , et al.: The HLA-DRB1*15:01-restricted Goodpasture’s T cell epitope induces GN. J Am Soc Nephrol 24: 419431, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 47.

    Ooi JD , Petersen J , Tan YH , Huynh M , Willett ZJ , Ramarathinam SH , et al.: Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells. Nature 545: 243247, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 48.

    Huart A , Josse AG , Chauveau D , Korach JM , Heshmati F , Bauvin E , et al.; French Society of Hemapheresis: Outcomes of patients with Goodpasture syndrome: A nationwide cohort-based study from the French Society of Hemapheresis. J Autoimmun 73: 2429, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 49.

    Marques C , Carvelli J , Biard L , Faguer S , Provôt F , Matignon M , et al.: Prognostic factors in anti-glomerular basement membrane disease: A multicenter study of 119 patients. Front Immunol 10: 1665, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 50.

    van Daalen EE , Jennette JC , McAdoo SP , Pusey CD , Alba MA , Poulton CJ , et al.: Predicting outcome in patients with anti-GBM glomerulonephritis. Clin J Am Soc Nephrol 13: 6372, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 51.

    Yang R , Otten MA , Hellmark T , Collin M , Björck L , Zhao MH , et al.: Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes. Nephrol Dial Transplant 25: 24792486, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 52.

    Soveri I , Mölne J , Uhlin F , Nilsson T , Kjellman C , Sonesson E , et al.: The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane disease. Kidney Int 96: 12341238, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 53.

    McAdoo SP , Tanna A , Hrušková Z , Holm L , Weiner M , Arulkumaran N , et al.: Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int 92: 693702, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 54.

    McCall AS , Bhave G , Pedchenko V , Hess J , Free M , Little DJ , et al.: Inhibitory anti-peroxidasin antibodies in pulmonary-renal syndromes. J Am Soc Nephrol 29: 26192625, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 55.

    Hahn BH , McMahon MA , Wilkinson A , Wallace WD , Daikh DI , Fitzgerald JD , et al.; American College of Rheumatology: American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) 64: 797808, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 56.

    Gordon C , Amissah-Arthur MB , Gayed M , Brown S , Bruce IN , D’Cruz D , et al.; British Society for Rheumatology Standards, Audit and Guidelines Working Group: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology (Oxford) 57: e1e45, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 57.

    Fanouriakis A , Kostopoulou M , Cheema K , Anders HJ , Aringer M , Bajema I , et al.: 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis 79: 713723, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 58.

    Almaani S , Meara A , Rovin BH : Update on lupus nephritis. Clin J Am Soc Nephrol 12: 825835, 2017 PubMed

  • 59.

    Anders HJ , Saxena R , Zhao MH , Parodis I , Salmon JE , Mohan C : Lupus nephritis. Nat Rev Dis Primers 6: 7, 2020 PubMed

  • 60.

    Stojan G , Petri M : Epidemiology of systemic lupus erythematosus: An update. Curr Opin Rheumatol 30: 144150, 2018 PubMed

  • 61.

    Maningding E , Dall'Era M , Trupin L , Murphy LB , Yazdany J . Racial and ethnic differences in the prevalence and time to onset of manifestations of systemic lupus erythematosus: The California Lupus Surveillance Project. Arthritis Care Res (Hoboken) 72: 622629, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 62.

    Moroni G , Vercelloni PG , Quaglini S , Gatto M , Gianfreda D , Sacchi L , et al.: Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Ann Rheum Dis 77: 13181325, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 63.

    Bajema IM , Wilhelmus S , Alpers CE , Bruijn JA , Colvin RB , Cook HT , et al.: Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: Clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93: 789796, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 64.

    Malvar A , Pirruccio P , Alberton V , Lococo B , Recalde C , Fazini B , et al.: Histologic versus clinical remission in proliferative lupus nephritis. Nephrol Dial Transplant 32: 13381344, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 65.

    De Rosa M , Azzato F , Toblli JE , De Rosa G , Fuentes F , Nagaraja HN , et al.: A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy. Kidney Int 94: 788794, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 66.

    Turner-Stokes T , Wilson HR , Morreale M , Nunes A , Cairns T , Cook HT , et al.: Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy. Kidney Int 92: 12231231, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 67.

    Sethi S , Madden BJ , Debiec H , Charlesworth MC , Gross L , Ravindran A , et al.: Exostosin 1/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol 30: 11231136, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 68.

    Mackay M , Dall’Era M , Fishbein J , Kalunian K , Lesser M , Sanchez-Guerrero J , et al.: Establishing surrogate kidney end points for lupus nephritis clinical trials: Development and validation of a novel approach to predict future kidney outcomes. Arthritis Rheumatol 71: 411419, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 69.

    Liu Z , Zhang H , Liu Z , Xing C , Fu P , Ni Z , et al.: Multitarget therapy for induction treatment of lupus nephritis: A randomized trial. Ann Intern Med 162: 1826, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 70.

    Zhang H , Liu Z , Zhou M , Liu Z , Chen J , Xing C , et al.: Multitarget therapy for maintenance treatment of lupus nephritis. J Am Soc Nephrol 28: 36713678, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 71.

    Rovin BH , Solomons N , Pendergraft WF 3rd , Dooley MA , Tumlin J , Romero-Diaz J , et al.; AURA-LV Study Group: A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. Kidney Int 95: 219231, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 72.

    Condon MB , Ashby D , Pepper RJ , Cook HT , Levy JB , Griffith M , et al.: Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Ann Rheum Dis 72: 12801286, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 73.

    Rovin BH , Furie R , Latinis K , Looney RJ , Fervenza FC , Sanchez-Guerrero J , et al.; LUNAR Investigator Group: Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study. Arthritis Rheum 64: 12151226, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 74.

    Gomez Mendez LM , Cascino MD , Garg J , Katsumoto TR , Brakeman P , Dall’Era M , et al.: Peripheral blood B cell depletion after rituximab and complete response in lupus nephritis. Clin J Am Soc Nephrol 13: 15021509, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 75.

    Chavarot N , Verhelst D , Pardon A , Caudwell V , Mercadal L , Sacchi A , et al.; Groupe Coopératif sur le Lupus Rénal: Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study. Medicine (Baltimore) 96: e7429, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 76.

    Kraaij T , Kamerling SWA , de Rooij ENM , van Daele PLA , Bredewold OW , Bakker JA , et al.: The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus. J Autoimmun 91: 4554, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 148 148 19
Full Text Views 292 292 43
PDF Downloads 405 405 59